Previous studies (28, 43) have shown that IVIM_f and IVIM_D* can be used to predict IDH genotypes in 2016 WHO glioblastomas, while no significant differences were found between IDH wild-type and IDH-mutant in WHO 2016 grade II-III gliomas. The gene discussed is IDH2; the disease is central nervous system cancer.